Wockhardt Submits New Drug Application to USFDA for Zidebactam-Cefepime
Wockhardt announced the submission of New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection












